← Justice NoteSubscribe
STYX. — Styx Advisory Partners
Justice NoteNo. 1 · Fall 2026
An empty courtroom at night, a medical exhibit of a spine on an easel lit beside the bench

Trial Consulting · Medical-Legal Visuals · Expert Networks

Trial Services Are Being Bought. Mostly by Court Reporters.

For decades this was a craft business. Who is buying it now, what they pay a premium for, and why the owners who do best are the ones who decide early.

By Zach Manis · Styx Advisory Partners · About a six-minute read

Styx Advisory Partners advises MediVisuals + High Impact, a company in this field, profiled here.

For decades this was a craft business: a founder, a few artists or consultants, and referrals from trial lawyers who trusted them. Since 2017, that has changed.

Private equity has learned what owners in this field already know. When verdicts grow, trial teams spend more on persuasion, and they buy it from people they trust.

The platforms doing the buying were mostly built on depositions and court reporting. They have been adding graphics, jury research and expert networks so they can sell a law firm everything from the first deposition to the verdict.

The mechanic that matters

Platforms pay their best prices while they are still assembling a national offer. Once each has its graphics firm, its jury firm and its expert network, they stop paying for capability and pay only for cash flow. The independents who waited sell to fewer, pickier buyers.

Who is buyingFive platforms. Most of them started in court reporting.

Each is backed by institutional capital and built to acquire, and each is trying to sell a law firm more of the case.

$25.6BCorporate verdicts of $10M+ in 2025, up 40.7%
35%Law firms using outside trial-graphics vendors in 2024, up from 22.7%
~14Add-ons IMS completed before its 2026 sale
197,118Actions pending in federal MDLs, fiscal 2025
PlatformBacked byTrial-services dealsWhat it means
Magna Legal ServicesOdyssey Investment Partners (2022)Creative Counsel (2015) · TrialGraphix (2023) · CogentEdge (2024)Graphics and witness prep added to a national court-reporting network
U.S. Legal SupportAbry Partners (2018)DecisionQuest (2019) · TrialEx (2023), merged as TrialQuest (2024)Bought two well-known names, then retired both under one brand
IMS Legal StrategiesUplift Investors (2026), from Trinity HuntAbout 14 add-ons, including The Focal Point, Litigation Insights and First CourtThe serial buyer. A new owner in 2026 means a new growth plan
DRCTrivest PartnersImmersion Legal (2025)A newer entrant buying jury and trial-technology teams
Expert InstituteLevine Leichtman Capital PartnersExpertConnect Litigation SupportExpert networks now trade as a platform category of their own

The court-reporting platforms buy because it lets them sell more to the same law-firm customer. The firms they want most are the ones that fill a gap in that offer. Firms that duplicate something the platform already has get much less interest.

A medical illustrator's drafting table at night: a knee drawn in colored pencil, an X-ray, a tablet showing the same anatomy
The record, the drawing, the exhibit. The work is the same whoever owns the studio.

What buyers actually pay forTwo firms with the same revenue can be valued millions of dollars apart.

Buyers don't price a litigation-support firm on its case count. They price what survives the founder's departure, and discount what doesn't.

Commands a premium

  • Repeat-firm relationships

    The same trial firms coming back case after case, across several of their partners.

  • Both sides of the verdict

    Plaintiff, defense, insurers and corporate counsel: a book that holds when one side has a bad legislative year.

  • A bench beneath the owner

    Consultants, illustrators and hot-seat technicians who run matters without the founder in the room.

  • Collected, not just billed

    Clear terms on contingency work, and receivables that turn on time.

  • Clean matter-level numbers

    Revenue and margin by case and service line, reconciled before anyone asks.

Gets discounted

  • Founder-held relationships

    If every lawyer calls the founder's cell, a buyer prices those calls as leaving with you.

  • A one-sided book

    All-plaintiff or all-defense work reads as exposure to a single tort-reform bill.

  • Concentration

    One firm or one mass tort above about 20% of revenue costs turns of multiple, or comes back as an earn-out.

  • Paid at settlement

    Invoices that wait for a case to resolve show up as working capital the buyer has to fund.

  • Answering one phone call

    The biggest discount of all: negotiating with one buyer, on their timeline and their information.

The Styx view

Almost every premium on the left can be built, and almost every discount on the right can be fixed, given time. In a partnership conversation they are also negotiable. The owners who do best walk in knowing which ones they own.

Why demand holds, and why buyers know it

  1. Fewer cases reach a jury. The ones that do are bigger. Fewer than 1% of federal civil cases go to trial, and the rest settle on the strength of the story each side can show.
  2. The rules now name the tools. Federal Rule of Evidence 107, in force since December 2024, expressly allows illustrative aids such as animations.
  3. Mass torts keep the pipeline full. Nearly two hundred thousand actions sit in federal multidistrict litigation, and each one needs exhibits, experts and jury work.

Spending on persuasion follows the stakes. That is why institutional capital is buying well-run independents rather than building from scratch.

Where I sit

Zach Manis

I grew up on the grounds of the state fish hatchery in Pine Ridge, South Carolina, the one people of my parents' generation still call Styx. My firm carries the name. I'm the founder of Styx Advisory and the senior advisor on every engagement the firm takes on: twenty years advising businesses through M&A, IPOs and capital decisions, on transactions from $20 million to $2.6 billion. In this field Styx advises MediVisuals + High Impact. I'd rather you know that on page one than discover it on page six.

If you run a trial-consulting, medical-visuals, expert or settlement-video firm and want a straight read on where it sits, including the case for staying independent, write me or call. A first conversation is confidential, costs nothing, and doesn't come with a follow-up campaign.

Zach Manis · 917-455-8604 · zim@styxadvisory.com

The Justice Note comes out quarterly. Read it, and the next one, at justice.styxadvisory.com

Platforms pay for capability only while they are still assembling it. The owners who do best are the ones who decide early.

Zach ManisFounder, Styx Advisory Partners · Charlotte, North Carolina

Sources: Marathon Strategies via Claims Journal (Aug 2026); U.S. Legal Support trial services survey; PE Professional (Apr 2026); U.S. Courts, Judicial Panel on Multidistrict Litigation statistics (FY2025); Federal Rules of Evidence, Rule 107 (eff. Dec 1, 2024); company press releases. Platform ownership as reported; verify before relying on it.

Next issue: expert networks

Who owns the national networks now, and what is left for the physician-led firms that never sold. Get it by email: subscribe here. Four a year, nothing else.